InvestSMART

Alcidion Group Limited (ASX: ALC) - Announcements

- Current share price for ALC : $0.100

ASX company news and announcements for Alcidion Group Limited (ALC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alcidion Group Limited (ALC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alcidion Group Limited (ALC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alcidion Group Limited (ALC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$135 Quarterly Results & Investor Conference Call Details 16 Jul 2019 4:34PM $0.165 $0.100 fallen by 39.39%
$135 Section 708A Cleansing Notice and Appendix 3B 16 Jul 2019 10:54AM $0.173 $0.100 fallen by 42.03%
$135 ALC awarded preferred provider for Medications Management 16 Jul 2019 9:03AM $0.160 $0.100 fallen by 37.50%
$135 Initial Director's Interest Notice 1 Jul 2019 8:54AM $0.125 $0.100 fallen by 20%
$135 Final Director's Interest Notice 1 Jul 2019 8:37AM $0.125 $0.100 fallen by 20%
$135 Western Sussex Hospitals Renew Patientrack Contract 26 Jun 2019 8:50AM $0.115 $0.100 fallen by 13.04%
$135 Alcidion Announces Non-Executive Director Appointment 25 Jun 2019 9:29AM $0.120 $0.100 fallen by 16.67%
$135 Release of Securities from Escrow 17 Jun 2019 8:29AM $0.135 $0.100 fallen by 25.93%
$135 Response to ASX Price Query 30 May 2019 3:52PM $0.123 $0.100 fallen by 18.37%
$135 Alcidion helps NSW Health build CDHR 20 May 2019 9:04AM $0.099 $0.100 risen by 1.01%
$135 Alcidion Investor Presentation May 2019 1 May 2019 8:36AM $0.094 $0.100 risen by 6.38%
$135 Change of Director's Interest Notice 29 Apr 2019 3:51PM $0.086 $0.100 risen by 16.28%
$135 Change of Director's Interest Notice 29 Apr 2019 1:57PM $0.083 $0.100 risen by 20.48%
$135 Appendix 4C - quarterly 23 Apr 2019 8:24AM $0.059 $0.100 risen by 69.49%
$135 Quarterly Results & Investor Conference Call Details 16 Apr 2019 8:41AM $0.053 $0.100 risen by 88.68%
$135 Change of Director's Interest Notice - Correction 4 Apr 2019 4:13PM $0.055 $0.100 risen by 81.82%
$135 Market Update 28 Mar 2019 9:05AM $0.063 $0.100 risen by 58.73%
$135 Ceasing to be a substantial holder 28 Mar 2019 9:02AM $0.063 $0.100 risen by 58.73%
$135 Brighton and Sussex University Hospitals select Patientrack 21 Mar 2019 9:22AM $0.060 $0.100 risen by 66.67%
$135 Alcidion Investor Presentation March 2019 18 Mar 2019 8:58AM $0.048 $0.100 risen by 108.33%
$135 Alcidion signs deal with Dartford and Gravesham NHS Trust 18 Mar 2019 8:54AM $0.048 $0.100 risen by 108.33%
$135 Alcidion Announces Joint Company Secretary Appointment 4 Mar 2019 1:12PM $0.040 $0.100 risen by 150%
$135 Alcidion signs ACT Health Patientrack extension 25 Feb 2019 1:23PM $0.046 $0.100 risen by 117.39%
$135 Alcidion FY19 Half Year Report and Appendix 4D 25 Feb 2019 8:51AM $0.040 $0.100 risen by 150%
$135 Appendix 4C - quarterly 29 Jan 2019 9:18AM $0.045 $0.100 risen by 122.22%

401 - 425 of 589 results

Page 17 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.